Opportunistic infections after liver transplantation in patients infected with human immunodeficiency virus

Liver Transplantation

Volumn 18, Issue 3, 2012, Pages 376-377

  Teicher, Elina ^a,b   Duclos Vallée, Jean Charles ^b,c,d  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATAZANAVIR; CORTICOSTEROID; EFAVIRENZ; FOSAMPRENAVIR; LAMIVUDINE; LOPINAVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITONAVIR; STAVUDINE; TACROLIMUS; TENOFOVIR;

COLITIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ESOPHAGUS CANDIDIASIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INVASIVE ASPERGILLOSIS; LETTER; LIVER TRANSPLANTATION; MORTALITY; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TUBERCULOSIS; ZYGOMYCOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE;

EID: 84857547366     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22481     Document Type: Letter

References (4)

1. Moreno A, Cervera C, Fortún J, Blanes M, Montejo E, Abradelo M, et al.; for Spanish Foundation for the Investigation and Prevention of Acquired Immunodeficiency Syndrome Orthotopic Liver Transplantation/Human Immunodeficiency Virus Cohort Investigators. Epidemiology and outcomes of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a Spanish Foundation for the Investigation and Prevention of Acquired Immunodeficiency Syndrome/Spanish Group for the Study of Acquired Immunodeficiency Syndrome prospective cohort study. Liver Transpl 2012; 18.
2. Duclos-Vallée JC, Tateo M, Teicher E, Roque-Afonso AM, Sebagh M, Antonini TM, et al. Results of liver transplantation in a large cohort of more than 100 HIV infected patients a monocentric experience [abstract]. Hepatology 2011; 54 (suppl 1): 361A.
3. de Vera ME, Dvorchik I, Tom K, Eghtesad B, Thai N, Shakil O, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant 2006; 6: 2983-2993.
4. Duclos-Vallée JC, Féray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, et al.; for THEVIC Study Group. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008; 47: 407-417. (Pubitemid 351280708)